ClinicalThought


Share

Program Content

Activities

  • HER2-negative early breast cancer
    Key Takeaways in the Management of HER2-Negative Early Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 08, 2024

    Expires: May 07, 2025

  • HER2-Negative EBC With gBRCA PV
    Key Takeaways in the Management of HER2-Negative Early Breast Cancer: Focus on Treating Patients With Pathogenic Variants in Germline BRCA
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 17, 2024

    Expires: May 16, 2025

Faculty

cover img faculity

Allison Butts, PharmD, BCOP

Clinical Pharmacy Specialist, Breast Oncology
Pharmacist Manager, Oncology
Program Director, PGY2 Hematology/Oncology Pharmacy Residency
UK Healthcare
Lexington, Kentucky

cover img faculity

Jordan Hill, PharmD, BCOP

Clinical Pharmacy Specialist, Breast Oncology
West Virginia University Cancer Institute
Morgantown, West Virginia

Provided by

ProCE Banner

Provided by ProCE, LLC, in partnership with Clinical Care Options

Supporters

Supported by educational grants from AstraZeneca and Merck Sharp & Dohme LLC.

AstraZeneca

Merck Sharp & Dohme, LLC

Partners

Clinical Care Options, LLC

ProCE Banner